1. Home
  2. LEE vs ONCY Comparison

LEE vs ONCY Comparison

Compare LEE & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lee Enterprises Incorporated

LEE

Lee Enterprises Incorporated

HOLD

Current Price

$8.95

Market Cap

160.1M

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.99

Market Cap

94.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEE
ONCY
Founded
1890
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Newspapers/Magazines
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.1M
94.0M
IPO Year
2025
2002

Fundamental Metrics

Financial Performance
Metric
LEE
ONCY
Price
$8.95
$0.99
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.33
AVG Volume (30 Days)
113.5K
1.1M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$543,955,000.00
N/A
Revenue This Year
$5.48
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.34
$0.33
52 Week High
$11.21
$1.51

Technical Indicators

Market Signals
Indicator
LEE
ONCY
Relative Strength Index (RSI) 58.41 47.79
Support Level $8.35 $0.94
Resistance Level $9.74 $1.08
Average True Range (ATR) 0.80 0.07
MACD -0.12 -0.01
Stochastic Oscillator 37.42 22.65

Price Performance

Historical Comparison
LEE
ONCY

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: